Literature DB >> 20585729

Prevalence of dyslipidemias in the Mexican National Health and Nutrition Survey 2006.

Carlos A Aguilar-Salinas1, Francisco J Gómez-Pérez, Juan Rull, Salvador Villalpando, Simón Barquera, Rosalba Rojas.   

Abstract

OBJECTIVE: To describe the prevalence of lipid abnormalities found in the Mexican National Health and Nutrition Survey 2006 (ENSANut 2006).
MATERIAL AND METHODS: Information was obtained from 4 040 subjects aged 20 to 69 years, studied after a 9- to 12-hour fast.
RESULTS: Median lipid concentrations were: cholesterol 198.5 mg/dl, triglycerides 139.6 mg/dl, HDL-cholesterol 39.0 mg/dl, non-HDL-cholesterol 159.5 mg/dl and LDL-cholesterol 131.5 mg/dl. The most frequent abnormality was HDL-cholesterol below 40 mg/dl with a prevalence of 60.5% (95%CI 58.2-62.8%). Hypercholesterolemia (> 200 mg/dl) had a frequency of abnormality of 43.6% (95%CI 41.4-46.0%). Only 8.6% of the hypercholesterolemic subjects knew their diagnosis. Hypertriglyceridemia (>or= 150 mg/dl) was observed in 31.5% (IC 95% 29.3-33.9%) of the population.
CONCLUSIONS: The ENSANUT 2006 data confirm that the prevalence of hypoalphalipoproteinemia and other forms of dyslipidemia in Mexican adults is very high.

Entities:  

Mesh:

Year:  2010        PMID: 20585729     DOI: 10.1590/s0036-36342010000700008

Source DB:  PubMed          Journal:  Salud Publica Mex        ISSN: 0036-3634


  41 in total

1.  Contribution of frailty markers in explaining differences among individuals in five samples of older persons.

Authors:  Nadia Sourial; Howard Bergman; Sathya Karunananthan; Christina Wolfson; Jack Guralnik; Hélène Payette; Luis Gutierrez-Robledo; Dorly J H Deeg; John D Fletcher; Maria T E Puts; Bin Zhu; François Béland
Journal:  J Gerontol A Biol Sci Med Sci       Date:  2012-03-28       Impact factor: 6.053

2.  Contribution of socioeconomic factors and health care access to the awareness and treatment of diabetes and hypertension among older Mexican adults.

Authors:  Hiram Beltrán-Sánchez; Flávia Cristina Drumond-Andrade; Fernando Riosmena
Journal:  Salud Publica Mex       Date:  2015

Review 3.  Genetic and environmental determinants of the susceptibility of Amerindian derived populations for having hypertriglyceridemia.

Authors:  Carlos A Aguilar-Salinas; Teresa Tusie-Luna; Päivi Pajukanta
Journal:  Metabolism       Date:  2014-03-30       Impact factor: 8.694

4.  Susceptibility background for type 2 diabetes in eleven Mexican Indigenous populations: HNF4A gene analysis.

Authors:  M A Granados-Silvestre; M G Ortiz-López; J Granados; S Canizales-Quinteros; Rosenda I Peñaloza-Espinosa; C Lechuga; V Acuña-Alonzo; K Sánchez-Pozos; M Menjivar
Journal:  Mol Genet Genomics       Date:  2017-07-07       Impact factor: 3.291

Review 5.  Effect of magnesium supplementation on lipid profile: a systematic review and meta-analysis of randomized controlled trials.

Authors:  Luis E Simental-Mendía; Mario Simental-Mendía; Amirhossein Sahebkar; Martha Rodríguez-Morán; Fernando Guerrero-Romero
Journal:  Eur J Clin Pharmacol       Date:  2017-02-09       Impact factor: 2.953

6.  The N342S MYLIP polymorphism is associated with high total cholesterol and increased LDL receptor degradation in humans.

Authors:  Daphna Weissglas-Volkov; Anna C Calkin; Teresa Tusie-Luna; Janet S Sinsheimer; Noam Zelcer; Laura Riba; Ana Maria Vargas Tino; Maria Luisa Ordoñez-Sánchez; Ivette Cruz-Bautista; Carlos A Aguilar-Salinas; Peter Tontonoz; Päivi Pajukanta
Journal:  J Clin Invest       Date:  2011-07-18       Impact factor: 14.808

7.  Cardiovascular risk factors' behavior during the early stages of the disease, in Hispanic rheumatoid arthritis patients: a cohort study.

Authors:  Irazú Contreras-Yáñez; Guillermo Guaracha-Basáñez; Virginia Pascual-Ramos
Journal:  Rheumatol Int       Date:  2019-10-12       Impact factor: 2.631

Review 8.  The panorama of familial hypercholesterolemia in Latin America: a systematic review.

Authors:  Roopa Mehta; Rafael Zubirán; Alexandro J Martagón; Alejandra Vazquez-Cárdenas; Yayoi Segura-Kato; María Teresa Tusié-Luna; Carlos A Aguilar-Salinas
Journal:  J Lipid Res       Date:  2016-10-24       Impact factor: 5.922

9.  Does metformin increase paraoxonase activity in patients with the metabolic syndrome? Additional data from the MEFISTO study.

Authors:  Eduardo Meaney; Patricia Sierra-Vargas; Alejandra Meaney; Martín Guzmán-Grenfell; Israel Ramírez-Sánchez; Juan Jose Hicks; Ivonne Olivares-Corichi; Guillermo Ceballos
Journal:  Clin Transl Sci       Date:  2012-06       Impact factor: 4.689

10.  Design and challenges of a randomized controlled trial for reducing risk factors of metabolic syndrome in Mexican women through water intake.

Authors:  Sonia Hernández-Cordero; Dinorah González-Castell; Sonia Rodríguez-Ramírez; María Ángeles Villanueva-Borbolla; Mishel Unar; Simón Barquera; Teresita González de Cossío; Juan Rivera-Dommarco; Barry M Popkin
Journal:  Salud Publica Mex       Date:  2013-12
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.